[HTML][HTML] Association of cardiovascular medications with adverse outcomes in a matched analysis of a national cohort of patients with COVID-19
Background The use of statins, angiotensin-converting enzyme inhibitors
(ACEIs)/angiotensin II receptor blockers (ARBs), and anticoagulants may be associated with …
(ACEIs)/angiotensin II receptor blockers (ARBs), and anticoagulants may be associated with …
Protective role of N-acetylcysteine and Sulodexide on endothelial cells exposed on patients' serum after SARS-CoV-2 infection
J Rajewska-Tabor, P Sosińska-Zawierucha… - Frontiers in Cellular …, 2023 - frontiersin.org
Severe acute respiratory syndrome coronavirus-2 causes hyperinflammation and activation
of coagulation cascade and, as a result, aggravates endothelial cell dysfunction. N …
of coagulation cascade and, as a result, aggravates endothelial cell dysfunction. N …
Perindopril and Losartan Attenuate Pro-Coagulation Factors in Human Adipocytes Exposed to SARS Cov-2 Spike Protein
M Meity Ardiana, IGR Suryawan… - … of physiology and …, 2023 - repository.unair.ac.id
Thrombotic events are highly prevalent in coronavirus disease 2019 (COVID-19), especially
in patients presenting with risk factors of adverse outcomes such as obesity. Recently, the …
in patients presenting with risk factors of adverse outcomes such as obesity. Recently, the …
[HTML][HTML] COVID-19-ассоциированная флебопатия как актуальная проблема современной флебологии
ВЮ Богачев, БВ Болдин, ПЮ Туркин… - …, 2022 - cyberleninka.ru
Введение. SARS-CoV-2 сопровождается развитием дисфункции венозного эндотелия,
которая может привести к развитию персистирующей флебопатии нижних …
которая может привести к развитию персистирующей флебопатии нижних …
Protective role of N-acetylcysteine and Sulodexide on endothelial cells after SARS-CoV-2 infection
J Rajewska-Tabor, P Sosińska-Zawierucha, M Pyda… - bioRxiv, 2023 - biorxiv.org
Severe acute respiratory syndrome coronavirus-2 causes hyperinflammation and activation
of coagulation cascade and in the result aggravates endothelial cell dysfunction. N …
of coagulation cascade and in the result aggravates endothelial cell dysfunction. N …
Kompleksowa opieka nad pacjentem z chorobą naczyń obwodowych tętnic i żył—rekomendacje zespołu ekspertów 2023
A Jawień, KJ Filipiak, A Doroszko… - Acta …, 2023 - journals.viamedica.pl
2.4. 2. Zabiegi wewnątrznaczyniowe w zakresie tętnic kończyn dolnych 16 2.4. 2.1. Odcinek
aortalno-biodrowy 17 2.4. 2.2. Odcinek udowo-podkolanowy 17 2.4. 2.3. Odcinek poniżej …
aortalno-biodrowy 17 2.4. 2.2. Odcinek udowo-podkolanowy 17 2.4. 2.3. Odcinek poniżej …